Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of Central Nervous System (CNS) and spine. Radiosurgery Systems are systems which utilize beams to deliver a focused dose of radiation to a targeted tumor. GlobalData uses proprietary data and analytics to provide a comprehensive report on the radiosurgery systems devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the radiosurgery systems market in China was Elekta followed by Varian Medical Systems and Accuray.
Radiosurgery Systems include Linear Accelerator (LINAC) Radiosurgery Systems and GammaKnife Radiosurgery Systems. LINAC Radiosurgery Systems works with collimated x-ray beam focused on an intracranial target. The source beam is positioned with the help of a motor-driven gantry or robot. GammaKnife Radiosurgery Systems is a non-invasive radiosurgery system which is used to treat tumors of brain. These systems use Cobalt-60 sources and radiation beams from approximately 200 different angles converge at a single point to treat tumors. 3-D pictures are obtained with help of stereotactic head frame which is attached to a patient. ‘Hybrid’ systems which are capable of delivering radiotherapy and radiosurgery are not tracked here.
The value of the radiosurgery systems devices market within China was expected to be over $70m in 2023.
For the latest complete market share analysis of radiosurgery systems device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
